Merck to Buy ArQule for $2.7 Billion -- Update

Date : 12/09/2019 @ 4:13PM
Source : Dow Jones News
Stock : ArQule Inc (ARQL)
Quote : 20.0  0.0 (0.00%) @ 1:00AM

Merck to Buy ArQule for $2.7 Billion -- Update

Historical Stock Chart

6 Months : From Oct 2019 to Apr 2020

Click Here for more ArQule Charts.
By Dave Sebastian and Colin Kellaher 

Merck & Co. said it is buying ArQule Inc. for about $2.7 billion, adding to its portfolio of cancer treatments beyond the company's top-selling immunotherapy drug Keytruda.

The purchase price, at $20 a share in cash, is more than double Friday's closing price of $9.66 for ArQule, a Burlington, Mass., biopharmaceutical company. Shares of ArQule were up 103% in morning trading Monday. Merck shares, which are up about 16% this year, declined 0.4%.

Merck said the deal would expand its oncology offerings into therapies that treat hematological malignancies. ArQule's experimental treatment ARQ 531 is in a Phase 2 dose-expansion study for the treatment of B-cell tumors such as chronic lymphocytic lymphoma.

The deal is expected to close in the first quarter of 2020.

Merck finance chief, Robert Davis, told The Wall Street Journal in October that the company's deal-making strategy remains focused on smaller, "bolt-on" acquisitions and not larger, transformative transactions.

The Kenilworth, N.J., drugmaker has been adding to its pipeline of drugs by buying cancer drugmakers with promising therapies and technologies such as Peloton Therapeutics Inc. and Tilos Therapeutics Inc.

The company booked more than $3 billion in Keytruda sales for the fiscal third quarter, a 62% year-over-year increase and about a quarter of the company's total revenue. Keytruda, which unleashes a patient's own immune system to fight tumors, was once an afterthought buried in Merck's research-and-development pipeline but has in the past few years become a commercial force for the company.

Write to Dave Sebastian at and Colin Kellaher at


(END) Dow Jones Newswires

December 09, 2019 10:58 ET (15:58 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest ARQL Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.